SC 13G
ITERUM THERAPEUTICS PLC
- Company
- Iterum Therapeutics plc
- Filed
- January 31, 2024
- Accession Number
- 0000902664-24-000843
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →